BioCentury
ARTICLE | Financial News

Synageva raises $102.2 million

January 5, 2013 12:35 AM UTC

Synageva BioPharma Corp. (NASDAQ:GEVA) raised $102.2 million through the sale of 2.2 million shares at $47.53 in a bumped-up follow-on underwritten by Morgan Stanley; JPMorgan; Cowen; Canaccord; and Leerink. Synageva proposed to raise up to $80 million on Thursday, when its share price was $47.87. Synageva was unchanged at $47.53 on Friday. ...